Discovery, Characterization and Manufacture of Peptide Radiopharmaceuticals

Showing results for 
Search instead for 
Did you mean: 

Discovery, Characterization and Manufacture of Peptide Radiopharmaceuticals

Published on ‎04-05-2024 01:02 PM by | Updated on ‎04-05-2024 01:02 PM

A new wave of drugs that achieve the targeted delivery of radioisotopes are rapidly gaining momentum and attracting significant excitement. As the discovery and development pipeline widens, and new drug approvals increase, the field is expanding and becoming more diverse in the strategies employed to deliver the cell-killing radioisotopes.
One area that is showing considerable promise is the incorporation of an isotope-chelating moiety into a peptide ligand for a cell surface receptor on the cancer cells of interest. In this webinar we will discuss strategies for the discovery and optimisation of new peptide ligands for such targets, as well as their synthesis, investigation of efficacy, metabolism and distribution, and ultimately their manufacture.
Key Learning Objectives:
  • Understand the latest developments in peptide radiopharmaceuticals
  • Learn how new peptide leads can be identified for this modality
  • See how the latest imaging technologies can help identify and characterize new diagnostic and therapeutic molecules
Who Should Attend:
  • Academic and industry scientists involved in radiopharmaceutical discovery, optimization, characterization and development. All levels from laboratory scientists to business leaders in this modality area.


Brought to you by:


jiazhi.pngJiazhi Liu,
Associate Director,
WuXi AppTec



shaowei.pngShaowei Wang,
Assistant Director, Molecular Imaging Center,
WuXi AppTec



alex.pngAlex Satz,
Executive Director, Head of Hits Europe,
WuXi AppTec



dave.pngDave Madge,
VP, Discovery Services,
WuXi AppTec



ann.pngAnn Thayer
Contributing Editor,
C&EN Media Group


Event has ended
You can no longer attend this event.

Tue, Apr 16, 2024 11:00 AM EDT
Tue, Apr 16, 2024 12:00 PM EDT
<a href=''>Register</a>
Labels (2)
0 Kudos
1 Comment